A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years

Vaccine

Volumn 24, Issue 35-36, 2006, Pages 6120-6128

  Marshall, H ^a   Nolan, T ^b,c   Roberton, D ^a   Richmond, P ^d   Lambert, S ^b,c   Jacquet, J M ^e   Schuerman, L ^e  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Booster; DTPa IPV; Local swelling reactions; Measles mumps rubella

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INACTIVATED VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY BLOOD LEVEL; APPETITE DISORDER; ARTICLE; BRONCHITIS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DROWSINESS; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; FEMALE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; IRRITABILITY; JOINT SWELLING; MALE; MEASLES; MUMPS; PAROTID GLAND DISEASE; PERTUSSIS; PHASE 3 CLINICAL TRIAL; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RUBELLA; SALIVARY GLAND DISEASE; SEROTYPE; SIDE EFFECT; SWELLING; TETANUS;

ANTIBODIES; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, SUBCUTANEOUS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; POLIOVIRUS VACCINE, INACTIVATED;

EID: 33746783789     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.017     Document Type: Article

References (33)

1. National Health and Medical Research Council. The Australian Immunisation Handbook. 8th ed. (2003), Australian Government Publishing Service, Canberra
2. Kraisinger M. Update on childhood immunization. Am J Health-Syst Pharm 55 (1998) 563-569
3. Salisbury D.M., and Olivé J.M. Immunization in Europe. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), WB Saunders Company, Philadelphia, PA 1387-1406
4. Collins C., Salt P., McCarthy N., Chantler T., Lane L., Hemme F., et al. Immunogenicity and safety of a low-dose diphtheria, tetanus, and acellular pertussis combination as a pre-school booster in UK children. Vaccine 22 (2004) 4262-4269
5. ACIR: 002A National Report. Number of children who have received valid vaccinations between 01 January 2004-31 December 2004.
6. Halsey N. Safety of combination vaccines: perception versus reality. Pediatr Infect Dis J 20 Suppl. 1 (2001) S40-S44
7. Keane M., Walter M., Patel B., Moorthy S., Bender Stevens R., Bradley K., et al. Confidence in vaccination: a parent model. Vaccine 23 (2005) 2486-2493
8. Andre F. Development and clinical application of new polyvalent combined paediatric vaccines. Vaccine 17 (1999) 1620-1627
9. Lieu T., Black S., and Ray G. The hidden costs of infant vaccination. Vaccine 19 (2000) 33-41
10. Grant C., Roberts M., Scragg R., Stewart J., Lennon D., Kivell D., et al. Delayed immunization and risk of pertussis in infants: unmatched case-control study. BMJ 326 (2003) 852-853
11. Andrews R., Herceg A., and Roberts C. Pertussis notifications in Australia, 1991 to 1997. CDI 21 (1997) 145-148
12. Halperin S., Scheifele D., Barreto L., Pim C., Guasparini R., Medd L., et al. Comparison of a fifth dose of a five-component acellular or whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J 18 (1999) 772-779
13. Pichichero M., Edwards K., Anderson E., et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four to six year old children. Pediatrics 105 1 (2000) 1-8
14. Gold M., Noonan S., Osbourn M., Precepa S., and Kempe A. Local reactions after fourth-dose of acellular pertussis vaccine in South Australia. MJA 179 (2003) 191-194
15. Woo E., Burwen D., Gatumu S., Ball R., and VAERS working group. Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system. CID 37 (2003) 351-358
16. Skowronski D., Remple V., Macnabb J., Pielak K., Patrick D., Halperin S., et al. Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity and anticipated impact. Pediatrics 112 (2003) e453-e459
17. Adverse Drug Reactions Advisory Committee (ADRAC). Extensive limb swelling and DTPa booster doses. Aust Adv Drug React Bull 20 (2001) 10
18. Rennels M. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Pediatr Infect Dis J 14 (2000) 196-198
19. Rennels M., Deloria M., Pichichero M., Losonsky G.A., Englund J.A., Meade B.D., et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105 1 (2000) 1-6
20. White S., and Freedman L. Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer 37 (1978) 849-857
21. Tichmann-Schumann I., Soemantri P., Behre U., Disselhoff J., Mahler H., Maechler G., et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent conjugate vaccine. Pediatr Infect Dis J 24 1 (2005) 70-77
22. Proc Stat Xact 5 for SAS Users. User Manuel, Cytel Software Corporation. Section 2002;14:265-326.
23. Yeh S.H., and Ward J.I. Strategies for development of combination vaccines. Pediatr Infect Dis J 20 (2001) S5-S9
24. Glode M. Combination vaccines: practical considerations for public health and private practice. Pediatr Infect Dis J 20 (2001) S19-S22
25. Godfroid F., Denoel P., de Grave D., Schuerman L., and Poolman J. Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses. Int J Med Microbiol 294 5 (2004) 269-276
26. Nolan T., Altmann A., Skeljo M., Streeton C., and Schuerman L. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine. Vaccine 23 (2004) 14-20
27. Fletcher M., Fabre P., Debois H., and Saliou P. Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature. Int J Infect Dis 8 (2004) 328-338
28. Capiau C., Poolman J., Hoet B., Bogaerts H., and Andre F. Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned. Vaccine 21 (2003) 2273-2287
29. Deforest A., Long S., Lischner H., Girone J., Clark J., Srinivasan N., et al. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and polio vaccines. Pediatrics 81 2 (1988) 237-246
30. Plotkin S., and Orenstein W. Vaccines (1999), W.B Saunders Company, Philadelphia
31. Tozzi A., Anemona A., Stefanelli P., Salmaso S., Atti M.L., Mastrantonio P., et al. Reactogenicity and immunogenicity at pre-school age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics 107 2 (2001) 1-9
32. National Health Medical Research Council. The Australian immunisation handbook. 7th ed. (2000), Australian Government Publishing Service, Canberra
33. Lloyd J., Haber P., Mootret G., Braun M., Rhodes P., Chen R., et al. Adverse event reporting rates following tetanus-diphtheria and tetanus toxiod vaccinations: data from the Vaccine adverse Event Reporting System (VAERS) 1991-1997. Vaccine 21 (2003) 3746-3750